ARDC funding outcomes: Monash receives current funding for future tech
5 February 2020 Monash University has secured $4.3m from the Australian Research Data Commons (ARDC) to lead four major data and cloud infrastructure science projects, which significantly advance the artificial intelligence (AI), data science and research technology capabilities…
Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia
7 February 2020 Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the…
Milestone for HIV diagnostic
7 February 2020 Burnet Institute warmly welcomes Nigeria’s approval of a Burnet-developed diagnostic for adoption in the National HIV Control Program. The Omega VISITECT® CD4 350 test is a simple, low-cost rapid HIV diagnostic that can identify whether…
New REDI grant funding validates ANDHealth model for digital health commercialisation
5 February 2020 ANDHealth will renew its commitment to turning innovative digital health ideas into commercial reality, after being named a beneficiary of a major new grant through its founding partner MTPConnect. The Federal Government’s Researcher Exchange and…
Sienna makes Board Appointment
6 February 2020 ASX RELEASE Melbourne, Australia: Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Tony Di Pietro as a Director of its Board. Tony has held the role of CFO and…
Sienna Increases European Presence Expanding into Finland with hTERT test
6 February 2020 ASX RELEASE Melbourne, Australia: Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Immuno Diagnostic Oy as an exclusive distributor in Finland. The distribution agreement provides Immuno Diagnostic with the right…
Trajan’s hemaPEN® included on TGA’s ARTG as first blood microsampling device for use in Australia
7 February 2020 Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the…
Gut reaction: how immunity ramps up against incoming threats
30 January 2020 A new study has revealed how the gut’s protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits. Professor Gabrielle Belz (left)…
On-shore commercial manufacture and wider subsidy for CAR T-Cell therapy
28 January 2020 Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment. Cell Therapies Pty Ltd, a company situated at Peter…
CSIRO to support nation’s bushfire rebuild
29 January 2020 CSIRO, Australia’s national science agency, has welcomed its role in delivering practical resilience measures in relation to bushfires and climate change, as the country faces continued extreme fire weather in the future. Announced by Prime…
On-shore commercial manufacture and wider subsidy for CAR T Cell therapy
28 January 2020 Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment. Cell Therapies Pty Ltd, a company situated at Peter…
Genetic drivers of myeloproliferative diseases revealed – WEHI
24 January 2020 Dr Melissa Call, Associate Professor Matthew Call, and Dr Jessica Bridgford led the study at the Walter and Eliza Hall Institute. Institute scientists have revealed seven new genetic mutations that cause myeloproliferative diseases – chronic…
